Stifel Financial’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1M | Buy |
11,363
+88
| +0.8% | +$7.58K | ﹤0.01% | 2454 |
|
|
2025
Q4 | $885K | Buy |
11,275
+1,170
| +12% | +$89K | ﹤0.01% | 2523 |
|
|
2025
Q3 | $677K | Buy |
10,105
+1,813
| +22% | +$130K | ﹤0.01% | 2628 |
|
|
2025
Q2 | $781K | Buy |
8,292
+4,902
| +145% | +$538K | ﹤0.01% | 2498 |
|
|
2025
Q1 | $402K | Buy |
3,390
+99
| +3% | +$13.5K | ﹤0.01% | 2827 |
|
|
2024
Q4 | $434K | Buy |
3,291
+39
| +1% | +$4.79K | ﹤0.01% | 2760 |
|
|
2024
Q3 | $422K | Sell |
3,252
-655
| -17% | -$77K | ﹤0.01% | 2775 |
|
|
2024
Q2 | $339K | Sell |
3,907
-213
| -5% | -$22.3K | ﹤0.01% | 2850 |
|
|
2024
Q1 | $452K | Sell |
4,120
-1,729
| -30% | -$174K | ﹤0.01% | 2674 |
|
|
2023
Q4 | $613K | Sell |
5,849
-600
| -9% | -$58.5K | ﹤0.01% | 2456 |
|
|
2023
Q3 | $678K | Buy |
6,449
+32
| +0.5% | +$4.1K | ﹤0.01% | 2315 |
|
|
2023
Q2 | $825K | Buy |
6,417
+77
| +1% | +$11.7K | ﹤0.01% | 2201 |
|
|
2023
Q1 | $1.11M | Buy |
6,340
+298
| +5% | +$53.4K | ﹤0.01% | 1977 |
|
|
2022
Q4 | $1M | Sell |
6,042
-199
| -3% | -$31.2K | ﹤0.01% | 2002 |
|
|
2022
Q3 | $879K | Sell |
6,241
-97
| -2% | -$17.7K | ﹤0.01% | 2063 |
|
|
2022
Q2 | $1.29M | Buy |
6,338
+273
| +5% | +$59.8K | ﹤0.01% | 1813 |
|
|
2022
Q1 | $1.55M | Buy |
6,065
+3,025
| +100% | +$822K | ﹤0.01% | 1819 |
|
|
2021
Q4 | $997K | Sell |
3,040
-1,019
| -25% | -$320K | ﹤0.01% | 2133 |
|
|
2021
Q3 | $1.23M | Buy |
4,059
+68
| +2% | +$19.3K | ﹤0.01% | 1921 |
|
|
2021
Q2 | $1.08M | Buy |
3,991
+63
| +2% | +$16K | ﹤0.01% | 2037 |
|
|
2021
Q1 | $956K | Buy |
3,928
+46
| +1% | +$12.7K | ﹤0.01% | 2016 |
|
|
2020
Q4 | $1.11M | Sell |
3,882
-68
| -2% | -$18.7K | ﹤0.01% | 1766 |
|
|
2020
Q3 | $1.01M | Sell |
3,950
-942
| -19% | -$224K | ﹤0.01% | 1628 |
|
|
2020
Q2 | $1.06M | Sell |
4,892
-838
| -15% | -$193K | ﹤0.01% | 1513 |
|
|
2020
Q1 | $1.29M | Sell |
5,730
-13
| -0.2% | -$3.21K | ﹤0.01% | 1272 |
|
|
2019
Q4 | $1.43M | Buy |
5,743
+4
| +0.1% | +$937 | ﹤0.01% | 1568 |
|
|
2019
Q3 | $1.36M | Hold |
5,739
| – | – | ﹤0.01% | 1561 |
|
|
2019
Q2 | $1.4M | Sell |
5,739
-113
| -2% | -$26.3K | ﹤0.01% | 1579 |
|
|
2019
Q1 | $1.35M | Sell |
5,852
-387
| -6% | -$87.5K | ﹤0.01% | 1477 |
|
|
2018
Q4 | $1.3M | Hold |
6,239
| – | – | ﹤0.01% | 1383 |
|
|
2018
Q3 | $1.16M | Sell |
6,239
-2
| -0% | -$403 | ﹤0.01% | 1586 |
|
|
2018
Q2 | $1.32M | Sell |
6,241
-566
| -8% | -$99K | ﹤0.01% | 1447 |
|
|
2018
Q1 | $1.01M | Buy |
+6,807
| New | +$928K | ﹤0.01% | 1556 |
|
Other funds holding MLAB
LPP
VCM
RIM
RA
Stifel Financial's MLAB Position: Q1 2026 in Review
Stifel Financial increased its Mesa Laboratories (MLAB) stake by 0.78% in Q1 2026, buying an estimated $7.58K and bringing the position to 11,363 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2454.
Stifel Financial first reported a position in MLAB in Q1 2018 and has held it in 33 quarters since. The position peaked at $1.55M in Q1 2022. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.
- Stifel Financial held 11,363 shares of Mesa Laboratories worth $1M as of Q1 2026.
- Stifel Financial bought 88 Mesa Laboratories shares in Q1 2026, an estimated $7.58K.
- Mesa Laboratories made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2454 holding.
- Stifel Financial first reported a position in Mesa Laboratories in Q1 2018 and has held it in 33 quarters since.
- Stifel Financial's Mesa Laboratories position peaked at $1.55M in Q1 2022.
- 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.